pLSC-5 Citations (4)

Originally described in: A split-Cas9 architecture for inducible genome editing and transcription modulation.
Zetsche B, Volz SE, Zhang F Nat Biotechnol. 2015 Feb 2. doi: 10.1038/nbt.3149. PubMed Journal

Articles Citing pLSC-5

Articles
Multimode drug inducible CRISPR/Cas9 devices for transcriptional activation and genome editing. Lu J, Zhao C, Zhao Y, Zhang J, Zhang Y, Chen L, Han Q, Ying Y, Peng S, Ai R, Wang Y. Nucleic Acids Res. 2018 Mar 16;46(5):e25. doi: 10.1093/nar/gkx1222. PubMed Associated Plasmids ScFv-2ERT2-V EF1a-Cas9-2XNES-2ERT2-GCN4-SV40-Zeo ScFv-2ERT2-VPH
HIT-Cas9: A CRISPR/Cas9 Genome-Editing Device under Tight and Effective Drug Control. Zhao C, Zhao Y, Zhang J, Lu J, Chen L, Zhang Y, Ying Y, Xu J, Wei S, Wang Y. Mol Ther Nucleic Acids. 2018 Dec 7;13:208-219. doi: 10.1016/j.omtn.2018.08.022. Epub 2018 Sep 1. PubMed Associated Plasmids EF1a-Cas9-2XNES-2ERT2
Human GBP1 is a microbe-specific gatekeeper of macrophage apoptosis and pyroptosis. Fisch D, Bando H, Clough B, Hornung V, Yamamoto M, Shenoy AR, Frickel EM. EMBO J. 2019 Jul 1;38(13):e100926. doi: 10.15252/embj.2018100926. Epub 2019 Jun 3. PubMed Associated Plasmids pLenti-Tet pGene-TAP-GBP1 pLenti-Tet-GBP1-C589A
Spatial and temporal control of gene manipulation in Drosophila via drug-activated Cas9 nucleases. Huynh N, Wang S, King-Jones K. Insect Biochem Mol Biol. 2020 May;120:103336. doi: 10.1016/j.ibmb.2020.103336. Epub 2020 Feb 24. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.